phosphatidylcholines has been researched along with fenofibrate in 6 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (fenofibrate) | Trials (fenofibrate) | Recent Studies (post-2010) (fenofibrate) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 3,058 | 529 | 1,354 |
Protein | Taxonomy | phosphatidylcholines (IC50) | fenofibrate (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 2.371 | |
Adenosine receptor A3 | Homo sapiens (human) | 5.701 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 2.118 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 2.371 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.701 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 8.633 | |
Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 1 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhmedzhanov, NM; Oganov, RG; Olfer'ev, AM; Ozerova, IN; Paramonova, IV; Pavlova, LI; Perova, NV | 1 |
Ikeda, E; Kawashima, Y; Kudo, N; Mitsumoto, A; Sakamoto, T; Tanaka, S; Wakabayashi, M; Yamazaki, T | 1 |
Ananthanarayanan, M; Boyer, JL; Ghonem, NS; Soroka, CJ | 1 |
Kleinebudde, P; Lenz, E; Page, S; Sprunk, A | 1 |
Fukushima, M; Kawakami, K; Miyazaki, A; Mohri, K; Sakuma, S; Sato, K; Yamamura, Y | 1 |
Amenitsch, H; Müllertz, A; Rades, T; Siqueira, SDVS; Tran, T | 1 |
6 other study(ies) available for phosphatidylcholines and fenofibrate
Article | Year |
---|---|
Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Cardiolipins; Cholesterol; Cholesterol, HDL; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipolysis; Lipoproteins, HDL; Lysophosphatidylcholines; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Simvastatin; Sphingomyelins; Triglycerides | 2001 |
Induction of 1-acylglycerophosphocholine acyltransferase genes by fibrates in the liver of rats.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Animals; Bezafibrate; Clofibric Acid; Fatty Acids; Fenofibrate; Fibric Acids; Gene Expression; Gene Expression Regulation; Liver; Male; Microsomes, Liver; Phosphatidylcholines; Rats; Rats, Wistar; RNA, Messenger; Stearoyl-CoA Desaturase | 2012 |
Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Bile Canaliculi; Biliary Tract; Cholestasis; Fenofibrate; Hep G2 Cells; Hepatocytes; Humans; Hypolipidemic Agents; Phosphatidylcholines; PPAR alpha; Primary Cell Culture; Promoter Regions, Genetic; Rats; Transcription, Genetic | 2014 |
Impact of fillers on dissolution kinetic of fenofibrate dry foams.
Topics: Disaccharides; Excipients; Fenofibrate; Glucose; Hypolipidemic Agents; Kinetics; Mannitol; Particle Size; Phosphatidylcholines; Solubility; Starch; Sugar Alcohols; Tablets; Technology, Pharmaceutical | 2015 |
Physicochemical Properties of Solid Phospholipid Particles as a Drug Delivery Platform for Improving Oral Absorption of Poorly Soluble Drugs.
Topics: Administration, Oral; Animals; Cyclohexanes; Drug Carriers; Drug Delivery Systems; Fenofibrate; Freeze Drying; Hydrophobic and Hydrophilic Interactions; Male; Micelles; Particle Size; Phosphatidylcholines; Phospholipids; Rats; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; tert-Butyl Alcohol; X-Ray Diffraction | 2017 |
In vitro and in vivo performance of monoacyl phospholipid-based self-emulsifying drug delivery systems.
Topics: Animals; Biological Availability; Castor Oil; Chemical Precipitation; Drug Delivery Systems; Emulsions; Fenofibrate; Gastric Mucosa; Glycerides; Intestinal Absorption; Male; Particle Size; Phosphatidylcholines; Rats, Sprague-Dawley | 2017 |